ClinicalTrialsFinder

Post-essential Thrombocythemia Myelofibrosis (PET-MF) Clinical Trials in Seoul

1 recruitingSeoul, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

Primary myelofibrosis (PMF)Post-polycythemia Vera Myelofibrosis (PPV-MF)Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Novartis Pharmaceuticals460 enrolled6 locationsNCT07357727